Error loading player

Valsartan Class Action

Published Jul 23, 2018 8:58 AM

A class action is being filed in a BC court today against the manufacturers of a the hypertension medication Valsartan, which was pulled from shelves on July 9, after it was found to contain a carcinogen. A Canadian woman who took Valsartan for high blood pressure developed breast cancer after being exposed to the carcinogen. She’s the leading client in the class action.

We get more from Rice Harbut Elliot Lawyer Anthony Leoni